MNTK Stock Analysis: Buy, Sell, or Hold?
MNTK - Montauk Renewables, Inc. Common Stock
$1.14
0.01 (0.88%)
▲
5d:
-8.8%
30d:
-29.63%
90d:
-31.74%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When MNTK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MNTK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MNTK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.09
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$2.54
55.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MNTK is currently trading at $1.14, which is considered oversold relative to its 30-day fair value range of $1.19 to $1.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.4) compared to its historical average (9.9). Remarkably, the market is currently pricing in an annual earnings decline of 18.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNTK is in a strong downtrend. Immediate support is located at $1.07, while resistance sits at $1.27.
Market Sentiment: MNTK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.59 (+127.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MNTK is in a strong downtrend. Immediate support is located at $1.07, while resistance sits at $1.27.
Market Sentiment: MNTK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.59 (+127.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.19 -
$1.54
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 127.0% below Wall St target ($2.59)
- CAUTION: 5-day price weakness (-8.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.19 -
$1.54
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.07
Resistance Level
$1.27
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.37
Wall Street Target
$2.59
(+127.0%)
Revenue Growth (YoY)
56.7%
Earnings Growth (YoY)
-69.6%
Profit Margin
1.0%
Valuation Discount vs History
-18.5% cheaper
PE vs Historical
5.4 vs 9.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.5%
(market-implied from PE analysis)
1-Year Target
$1.03
(-10%)
2-Year Target
$0.92
(-19%)
3-Year Target
$0.83
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→10)
$1.53
(+34%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 32.9%)
$10.24
(+798%)
Base:
(SPY PE: 5.4, Growth: 32.9%)
$2.68
(+135%)
Bear:
(PE: 4.6, Growth: 32.9%)
$2.27
(+100%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (6x PE), but valuation improves significantly next year (5x PE) as earnings recover.
Forward PE: 5.58 | Forward EPS (Implied): $0.21
Bull Case
$1.41
(+21%)
Analyst growth 15.0%, PE expands to 5.9
Base Case
$1.17
(0%)
Market implied 0.0%, PE stable at 5.6
Bear Case
$0.89
(-24%)
Severe decline -15.0%, PE contracts to 5.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.4 to 9.9
Stabilization Target:
$2.10
(+84.2%)
PE Expansion Potential:
+84.2%
Share & Embed Analysis
Last updated: April 02, 2026 9:56 PM ET
Data refreshes hourly during market hours. Next update: 10:56 PM
Data refreshes hourly during market hours. Next update: 10:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNTK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$516 | 61 BUY |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$388 | 56 HOLD |
|
IFF
International Flavors & … |
STRONG BUY
22 analysts |
$91 | 62 BUY |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$308 | 62 BUY |
|
DD
Dupont De Nemours Inc |
STRONG BUY
20 analysts |
$53 | 59 HOLD |
